A Novel Link Between SUMO Modification and Cancer Metastasis
5.Shevde LA, Welch DR. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett2003; 198:1-20.
6.Steeg PS. Metastasis suppressors alter the signal transduction of cancer cell. Nature RevCancer 2002; 3:55-63.
7.Petrylak DP. Metastases suppressors and prostate cancer. Nature Med 1995; 1:739-40.8.Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, RoseDW, Sawyers CL, Rosenfeld MG, Baek SH. Transcriptional regulation of a metastasis sup-pressor gene by Tip60and β-catenincomplexes. Nature 2005; 434:921-6.
9.Kim JH, Choi HJ, Kim B, Kim MH, Lee JM, Kim IS, Lee MH, Choi SJ, Kim KI, KimSI, Chung CH, Baek SH. Roles of SUMOylation of a reptin chromatin-remodeling com-plex in cancer metastasis. Nature Cell Biol 2006; 8:631-9.
10.Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J,
Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apop-tosis. Cell 2000; 102:463-73.
11.Baek SH, Ohgi KA, Rose, DW, Koo, EH, Glass CK, Rosenfeld MG. Exchange of N-CoR
corepressor and Tip60 coactivator complexes links gene expression by NF-κBand β-amy-loidprecursor protein. Cell 2002; 110:55-67.
12.Feng Y, Lee N, Fearon ER. TIP49regulates β-catenin-mediated neoplastic transformation
and T-cellfactor target gene induction via effects on chromatin remodeling. Cancer Res2003; 63:8726-34.
13.Kanemaki M, Kurokawa Y, Matsu-ura T, Makino Y, Masani A, Okazaki K, Morishita T,
Tamura TA. TIP49b, a new RuvB-like DNA helicase, is included in a complex togetherwith another RuvB-like DNA helicase, TIP49a. J Biol Chem 1999; 274:22437-44.
14.Jonsson ZO, Jha S, Wohlschlegel JA, Dutta A. Rvb1p/Rvb2p recruits Arp5p and assemble
a functional Ino80 chromatin remodeling complex. Mol Cell 2004; 16:465-77.
15.Francis NJ, Saurin AJ, Shao Z, Kingston RE. Reconstitution of a functional core polycomb
repressive complex. Mol Cell 2001; 8:545-56.
16.Bauer A, Chauvet S, Huber O, Usseglio F, Rothbacher U, Aragnol D, Kemler R, Pradel J.
Pontin52 and Reptin52 function as antagonistic regulators of β-catenin signaling activity.EMBO J 2000; 19:6121-30.
17. Rottbauer W, Saurin AJ, Lickert H, Shen X, Burns CG, Wo ZG, Kemler R, Kingston R,
Fishman M. Reptin and pontin antagonistically regulate heart growth in zebrafish embryos.Cell 2002; 111:661-72.
18.Billin AN, Thirlwell H, Ayer DE. β-catenin-histone deacetylase interactions regulate the
transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 2000;20:6882-90.
19.Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris
A, Rose DW, Rosenfeld MG. Regulated subset of G1growth-control genes in response toderepression by the Wntpathway. Proc Natl Acad Sci USA 2003; 100:3245-50.
20.Cheshire DR, Isaacs WB. β-Catenin signaling in prostate cancer: An early perspective.
Endocr Relat Cancer 2003; 10:537-60.
21.Clever H. Wnt breakers in colon cancer. Cancer Cell 2004; 5:5-6.
22.Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signal-ing through β-catenin. Science 2002; 296:1644-6.
23.Chesire DR, Ewing CM, Gage WR, Isaacs WB. In vitro evidence for complex modes of
nuclear β-cateninsignaling during prostate growth and tumorigenesis. Oncogene 2002;21:2679-94.
24.Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol
2003; 4:690-9.
25.Gill G. SUMOand ubiquitin in the nucleus: Different functions, similar mechanisms?
Genes Dev 2004; 18:2046-59.
26.Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: A plea of no
contest. Trends Cell Biol 2005; 15525-32.
27.Hay RT. SUMO: A history of modification. Mol Cell 2005; 18:1-12.
28.Garcia-Wilson E, Perkins ND. P21WAF1/CIP1 regulates the p300 SUMOylation motif
CRD1 through a C-terminal domain independently of Cyclin/CDK binding. Cell Cycle2005; 4:1113-9.
29.Boggio R, Chiocca S. Gam1 and the SUMO pathway. Cell Cycle 2005; 4:533-5.
30.Rizos, H, Woodruff S, Kefford RF. P14ARF interacts with the SUMO-conjugating enzyme
Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle 2005; 4:597-603.31.Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73:355-82.
32.Kim KI, Baek SH, Chung CH. Versatile protein tag, SUMO: Its enzymology and biolog-ical function. J Cell Physiol 2002; 191:257-268.
33.Haracska L, Torres-Romos CA, Johnson RE, Prakash S, Prakash L. Opposing effects of
ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNAlesions in Saccharomyces cerevisiae. Mol Cell Biol 2004; 24:4267-74.
34.Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA
repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002;419:135-141.
35.Ulrich HD, Vogel S, Davies AA. SUMO keeps a check on recombination during DNA
replication. Cell Cycle 2005; 4:1699-1702.
36.Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature
1999; 398:246-51.
37.Kim KI, Baek SH, Jeon YJ, Nishimori S, Suzuki T, Uchida S, shimbara N, Saitoh H,
Tanaka K, Chung CH. A new SUMO-1-specific protease, SUSP1, that is highly expressedin reproductive organs. J Biol Chem 2000; 275:14102-6.
38.Bachant J, Alcasabas A, Blat Y, Kleckner N, Elledge SJ. The SUMO-1 isopeptidase Smt4
is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomeraseII. Mol Cell 2002; 9:1169-82.
39.Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier
SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998; 17:61-70.40.Buschmann T, Fuchs SY, Lee CG, Ronai Z. SUMO-1 modification of mdm2 prevents its
self-ubiquitination and increases mdm2 ability to ubiquitinate p53. Cell 2000;101:753-62.
41.Bies J, Markus J. Wolff L. Covalent attachment of SUMO-1 protein to the negative regu-latory domain of the c-Myb transcription factor modifies its stability and transactivationcapacity. J Biol Chem 2002; 277:8999-9009.
42.Schmidt D, Muller S. Members of the PIAS family acts as SUMO ligases for c-Jun and p53
and repress p53 activity. Proc Natl Acad Sci USA 2002; 99:2872-7.
43.Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D,
Fomenkov A, Ratovitski EA. Altered sumoylation of p63 contricutes to the split-hand/footmalformation phenotype. Cell Cycle 2004; 3:1587-96.
44.Besten WD, Kuo ML, Williams RT, Sherr CJ. Myeloid leukemia-associated nucleophos-min mutants perturb p53-dependent and independent activities of the Arftumor suppres-sor protein. Cell Cycle 2005; 4:1593-8.
45.Ghioni P, D’lessandra Y, Mansueto G, Jaffray E, Hay RT, Lantria GL, Guerrini L. The pro-tein stability and transcriptional activity of p63 are regulated by SUMO-1 conjugation.Cell Cycle 2005; 4:183-90.
46.Ghosh M, Weghorst K, Berberich SJ. MdmX inhibits ARF mediated Mdm2 sumoylation.
Cell Cycle 2005; 4:604-8.
47.Alarcon-Vargas D, Ronai Z. SUMO in cancer-Wrestlers wanted. Cancer Biol and Therapy
2002; 1:237-42.
doc.guandang.net Cycle1495
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
热门文档